18. Nedeltcheva A.V., Scheer F.A. Metabolic effects of sleep disruption, links to obesity and diabetes. Curr Opin Endocrinol Diabetes Obes. 2014; 21 (4): 293–8.
19. Chong Y., Fryar C.D., Gu Q. Prescription sleep aid use among adults: United States, 2005–2010. In: NCHS Data Brief No. 127. Hyattsville, MD : National Center for Health Statistics, 2013.
20. Kripke D.F., Langer R.D., Kline L.E. Hypnotics’ association with mortality or cancer: a matched cohort study. BMJ Open. 2012; 2 (1): e000850.
21. Koch S., et al. Effectiveness of sleep management strategies for residents of aged care facilities: findings of a systematic review. J Clin Nur. 2006; 15 (10): 1267–75.
22. Tasali E., et al. The effects of extended bedtimes on sleep duration and food desire in overweight young adults: a home-based intervention. Appetite. 2014; 80: 220–4.
23. Chaput J.P., et al. Longer sleep duration associates with lower adiposity gain in adult short sleepers. Int J Obes. 2012; 36 (5): 752–6.
24. Potter G.D.M., et al. Circadian rhythm and sleep disruption: causes, metabolic consequences, and countermeasures. Endocr Rev. 2016; 37 (6): 584–608.
25. Provencio I., et al. Phototransduction by retinal ganglion cells that set the circadian clock. Neurosci Biobehav Rev. 1998; 395 (RC 191): 224.
26. Chaput J.P., et al. The role of insufficient sleep and circadian misalignment in obesity. Nat Rev Endocrinol. 2023; 19 (2): 82–97.
27. Rodrigues G.D., et al. Obesity and sleep disturbances: the «chicken or the egg» question. Eur J Intern Med. 2021; 92: 11–6.
28. Leproult R., Holmbäck U., Van Cauter E. Circadian misalignment augments markers of insulin resistance and inflammation, independently of sleep loss. Diabetes. 2014; 63 (6): 1860–9.
29. Lin J., et al. Associations of short sleep duration with appetite-regulating hormones and adipokines: a systematic review and meta-analysis. Obes Rev. 2020; 21 (11): e13051.
30. Scheer F.A.J.L., et al. Adverse metabolic and cardiovascular consequences of circadian misalignment. Proc Natl Acad Ssi USA. 2009; 106 (11): 4453–8.
31. Balieiro L.C.T., et al. Nutritional status and eating habits of bus drivers during the day and night. Chronobiol Int. 2014; 31 (10): 1123–9.
32. Mota M.C., et al. Dietary patterns, metabolic markers and subjective sleep measures in resident physicians. Chronobiol Int. 2013; 30 (8): 1032–41.
33. Crispim C.A., et al. Adipokine levels are altered by shiftwork: a preliminary study. Chronobiol Int. 2012; 29 (5): 587–94.
34. Padilha H.G., et al. Metabolic responses on the early shift. Chronobiol Int. 2010; 27 (5): 1080–92.
35. Roenneberg T., et al. Social jetlag and obesity. Curr Biol. 2012; 22 (10): 939–43.
36. Mannarino M.R., Di Filippo F., Pirro M. Obstructive sleep apnea syndrome. Eur J Intern Med. 2012; 23 (7): 586–93.
37. Huon L.K.A., Guilleminault C. A succinct history of sleep medicine. Adv Otorhinolaryngol. 2017; 80: 1–6.
38. Young T., Peppard P.E., Gottlieb D.J. Epidemiology of obstructive sleep apnea: a population health perspective. Am J Respir Crit Care Med. 2002; 165 (9): 1217–39.
39. Senaratna C.V., et al. Prevalence of obstructive sleep apnea in the general population: a systematic review. Sleep Med Rev. 2017; 34: 70–81.
40. Peppard P.E., et al. Increased prevalence of sleep-disordered breathing in adults. Am J Epidemiol. 2013; 177 (9): 1006–14.
41. Horstmann S., et al. Sleepiness-related accidents in sleep apnea patients. Sleep. 2000; 23 (3): 383–9.
42. Knauert M., et al. Clinical consequences and economic costs of untreated obstructive sleep apnea syndrome. World J Otorhinolaryngol Head Neck Surg. 2015; 1 (1): 17–27.
43. Aloia M.S., et al. Neuropsychological sequelae of obstructive sleep apnea-hypopnea syndrome: a critical review. J Int Neuropsychol Soc. 2004; 10 (5): 772–85.
44. Madkikar N., Pandey S., Ghaisas V. Multi level single stage: barbed reposition pharyngoplasty and nasal surgery in treatment of OSA – our experience. Indian J Otolaryngol Head Neck Surg. 2019; 71 (3): 309–14.
45. Cavaliere M., Russo F., Iemma M. Awake versus drug-induced sleep endoscopy: evaluation of airway obstruction in obstructive sleep apnea/hypopnoea syndrome. Laryngoscope. 2013; 123 (9): 2315–8.
46. Kuvat N., Tanriverdi H., Armutcu F. The relationship between obstructive sleep apnea syndrome and obesity: a new perspective on the pathogenesis in terms of organ crosstalk. Clin Respir J. 2020; 14 (7): 595–604.
47. Arias M.A., et al. CPAP decreases plasma levels of soluble tumour necrosis factor-α receptor 1 in obstructive sleep apnoea. Eur Respir J. 2008; 32 (4): 1009–15.
48. Pillar G., Shehadeh N. Abdominal fat and sleep apnea: the chicken or the egg? Diabetes Care. 2008; 31 (7): S 303–9.
49. Framnes S.N., Arble D.M. The bidirectional relationship between obstructive sleep apnea and metabolic disease. Front Endocrinol (Lausanne). 2018; 9: 440.
50. Ip M.S., et al. Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000; 118 (3): 580–6.
51. Johansson K., et al. Effect of a very low energy diet on moderate and severe obstructive sleep apnoea in obese men: a randomised controlled trial. BMJ. 2009; 339 (7734): b4609.
52. Grimaldi D., Beccuti G. Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications. Diabetes Care. 2014; 37 (2): 355–63.
53. Lallukka T., et al. Associations of relative weight with subsequent changes over time in insomnia symptoms: a follow-up study among middle-aged women and men. Sleep Med. 2012; 13 (10): 1271–9.